Pharmaceutical Sciences
•
0 likes•303 views
The document is a presentation by Obaid Ali on microbiology and pharmaceutical transformation. It discusses topics like clinical trials, new and generic drug manufacturing, vigilance, research, microbiology, human safety and efficacy verification, quality claims, consistency, contamination, surveillance, and signals from vigilance. Ali has experience working at the FDA and Health Canada and is currently leading scientific transformation initiatives at DRAP and advising the Centre for Quality Science.
Report
Share
Report
Share
Download to read offline
Recommended
INSHAALLAH
Pharmaceutical Quality & Regulatory Sciences (PQRS) aims to embrace knowledge and moral economy in pharmaceutical sciences through shift and transformation to enhance alignment with modern science. PQRS will provide consultation, trainings, and independent projects to facilitate improvements in regulatory submissions and operations, quality compliance, emerging issues in data sciences and data integrity, and developing progressive policies to evolve with the pharmaceutical quality field. The overall objective is to create meaningful change in managing values, dignity, trust and prosperity.
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
The document summarizes a presentation on the pharmaceutical regulatory science landscape in 2015. It discusses:
1) Changes and emerging trends in regulatory sciences, including increased globalization and harmonization efforts.
2) Quality metrics and using data to understand industry performance and identify issues.
3) Shifting business models, including more outsourcing and the need for continuous quality improvements.
4) Ensuring data integrity and addressing challenges like lack of integrity raising doubts about safety.
Pharmaceutical Regulations Drive
This document discusses pharmaceutical regulations and their impact on ensuring sterility and quality control. It addresses how strict definitions of sterility are defined quantitatively in terms of probability of a non-sterile unit. Proper management of aseptic processing areas and personnel training are essential to maintaining sterility. Inspectors focus on facilities, equipment, materials, and documentation to ensure quality management systems prevent inferior products. Sources of particulate contamination include environmental factors, packaging materials, product interactions, and process issues. Intravenous administration of particulates carries the highest risk, as particles can disseminate throughout the body and block vessels. Large particle loads, irregular shapes, and vulnerable patient populations increase risks of adverse effects.
Obaid & Roohi Centre for Quality Sciences - ORCQS
The document describes the Centre for Quality Sciences (ORCQS), a consulting service founded by Obaid and Roohi to provide services related to pharmaceutical quality and regulatory sciences. ORCQS aims to facilitate improvements in pharmaceutical submissions, technical operations, and quality management systems through strategic consultation, training programs, and independent projects. Their services include consultation, training, compliance assessments, and strategic planning to help clients navigate evolving regulations and standards in pharmaceutical quality.
Training on "GMP of the 21st Century"
1) The document announces a training session on Good Manufacturing Practices (GMP) of the 21st century to be held on April 4th, 2021. It discusses how GMP standards have evolved over time to focus more on product development, process understanding and control strategies.
2) GMP via a quality management system is important for ensuring drug quality and preventing errors, as testing a small sample cannot guarantee the quality of an entire batch. Advances in technology are reshaping GMP requirements.
3) The training methodology will include tutorials, interactive discussions, and real-world case studies to describe regulatory expectations and keep learning objectives aligned. Participants will be assessed in real-time.
Cdsco gcp different secctions
This document discusses the key differences between CDSCO-GCP guidelines. It covers 7 sections: definitions of good clinical practice; pre-requisites for clinical trials; responsibilities of sponsors, monitors and investigators; documentation and validation of electronic data; quality assurance systems; statistical analysis plans; and special concerns for certain types of clinical trials like vaccines, contraceptives and herbal remedies. The overall purpose is to outline the guidelines for designing, conducting and reporting clinical research studies involving human subjects.
Pharmaceutical Regulaions; Emergence & Complexity
Guest Speaker to MSc, students
Health Reforms of Health Policy & Management
Aga Khan University and Hospital, Karachi
Harmonization and Opportunites (Nov 2015)
An Outline on importance of Harmonization to deliver safe, efficacious and quality drugs to every body of globe
Recommended
INSHAALLAH
Pharmaceutical Quality & Regulatory Sciences (PQRS) aims to embrace knowledge and moral economy in pharmaceutical sciences through shift and transformation to enhance alignment with modern science. PQRS will provide consultation, trainings, and independent projects to facilitate improvements in regulatory submissions and operations, quality compliance, emerging issues in data sciences and data integrity, and developing progressive policies to evolve with the pharmaceutical quality field. The overall objective is to create meaningful change in managing values, dignity, trust and prosperity.
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
The document summarizes a presentation on the pharmaceutical regulatory science landscape in 2015. It discusses:
1) Changes and emerging trends in regulatory sciences, including increased globalization and harmonization efforts.
2) Quality metrics and using data to understand industry performance and identify issues.
3) Shifting business models, including more outsourcing and the need for continuous quality improvements.
4) Ensuring data integrity and addressing challenges like lack of integrity raising doubts about safety.
Pharmaceutical Regulations Drive
This document discusses pharmaceutical regulations and their impact on ensuring sterility and quality control. It addresses how strict definitions of sterility are defined quantitatively in terms of probability of a non-sterile unit. Proper management of aseptic processing areas and personnel training are essential to maintaining sterility. Inspectors focus on facilities, equipment, materials, and documentation to ensure quality management systems prevent inferior products. Sources of particulate contamination include environmental factors, packaging materials, product interactions, and process issues. Intravenous administration of particulates carries the highest risk, as particles can disseminate throughout the body and block vessels. Large particle loads, irregular shapes, and vulnerable patient populations increase risks of adverse effects.
Obaid & Roohi Centre for Quality Sciences - ORCQS
The document describes the Centre for Quality Sciences (ORCQS), a consulting service founded by Obaid and Roohi to provide services related to pharmaceutical quality and regulatory sciences. ORCQS aims to facilitate improvements in pharmaceutical submissions, technical operations, and quality management systems through strategic consultation, training programs, and independent projects. Their services include consultation, training, compliance assessments, and strategic planning to help clients navigate evolving regulations and standards in pharmaceutical quality.
Training on "GMP of the 21st Century"
1) The document announces a training session on Good Manufacturing Practices (GMP) of the 21st century to be held on April 4th, 2021. It discusses how GMP standards have evolved over time to focus more on product development, process understanding and control strategies.
2) GMP via a quality management system is important for ensuring drug quality and preventing errors, as testing a small sample cannot guarantee the quality of an entire batch. Advances in technology are reshaping GMP requirements.
3) The training methodology will include tutorials, interactive discussions, and real-world case studies to describe regulatory expectations and keep learning objectives aligned. Participants will be assessed in real-time.
Cdsco gcp different secctions
This document discusses the key differences between CDSCO-GCP guidelines. It covers 7 sections: definitions of good clinical practice; pre-requisites for clinical trials; responsibilities of sponsors, monitors and investigators; documentation and validation of electronic data; quality assurance systems; statistical analysis plans; and special concerns for certain types of clinical trials like vaccines, contraceptives and herbal remedies. The overall purpose is to outline the guidelines for designing, conducting and reporting clinical research studies involving human subjects.
Pharmaceutical Regulaions; Emergence & Complexity
Guest Speaker to MSc, students
Health Reforms of Health Policy & Management
Aga Khan University and Hospital, Karachi
Harmonization and Opportunites (Nov 2015)
An Outline on importance of Harmonization to deliver safe, efficacious and quality drugs to every body of globe
Pharmaceuticals Dashboard 2021
This document announces a professional development session on the pharmaceuticals dashboard for 2021. It will discuss topics like uncertainty in quality, the future of manufacturing and regulations, and competitiveness with trade barriers. The session aims to help professionals mature their skills and align with emerging expectations. It will use tutorials, discussions, examples and case studies. Participant assessment will be confidential. The session facilitators have extensive regulatory experience in Pakistan and international agencies. It will be held on December 19th in Karachi with a small group size.
Process development
The document discusses the process of developing, optimizing, characterizing, and commercializing a pharmaceutical product. It involves designing a manufacturing process to consistently deliver the intended effects of the drug product. Process development includes determining facility, equipment, materials, procedures, and validation. Optimization compares lead compounds to select those with the greatest potential to be safe and effective medicines. Characterization tests understand the physical and chemical properties of materials. Commercialization requires approvals from regulators and establishing manufacturing, distribution, and marketing capabilities to introduce the product into markets. The goal is to produce a drug that is safe, effective, and affordable to improve patient health.
Outsourcing in Clinical Research
Outsourcing is a Cost-effective strategy when used properly and at present is gaining more and more importance. Here's a short presentation about the importance of outsourcing in Clinical research.
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Best Practices - Injectable Packaging Lines
In the past couple of years we have seen many companies recalling sterile products, primarily due to the problems related to particulate matter and/ or sterility assurance. These problems are not only a potential threat to the patient health, but also lead to short supply due to contamination, manufacturing problems, or product discontinuation. Sterile dosage forms are vulnerable to both microbial and particulate contamination, which has been traced to glass and packaging materials, problems such as leaching and sorption and moreover the manufacturing/ operating practices.
Recently, in an industry workshop I had shared my thoughts, views, experiences and study findings on this topic and I am happy to share the same with you. I hope this will be useful…
Drug Regulatory Affairs
Drug Regulatory Affairs refers to all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation.
0rganisation of pharmaceutical industry
This document discusses organizational structures for pharmaceutical quality assurance. It states that the heads of production and quality control must be independent of each other according to EU GMP guidelines. It also lists the typical educational backgrounds needed for various roles in pharmaceutical production, quality assurance/quality control, and management. Finally, it provides a flow chart illustrating the process flow from receiving to shipping in a pharmaceutical manufacturing facility.
Drug Regulatory Affairs
This document provides an overview of regulatory affairs for drugs. It defines key terms like regulatory affairs, dossier, CTD, eCTD, DMF, NDA, ANDA, and INDA. It describes the role of regulatory affairs experts in guiding product development according to regulatory requirements, compiling dossiers for submission, and ensuring post-marketing compliance. The document outlines a 10 step process for regulatory product development and regulatory submission preparation. It also discusses quality management systems for regulatory compliance and the role of regulatory affairs in marketing and advertising compliance.
Role of CRO’s in Medical Innovation and Drug Development
Critical medical conditions such as new threats from chronic diseases and their debilitating conditions require quick responses and consistent attempts on a global level. Therefore, when the medical equipment and pharmaceutical biotechnology companies are in need to introduce efficient and effective drugs faster to the market, that is the time when they also need partners who are able to collaborate and assure them effortless development and service delivery.
Regulatory Affairs as a Career Path
The document provides an overview of regulatory affairs as a career. It discusses why regulatory is an important and impactful field, the types of work involved including advising companies on regulations and preparing submissions. It outlines the growth potential within regulatory affairs and necessary skills such as being analytical and having strong writing abilities. The document also discusses where to learn about regulations from sources like the FDA and how to continue self-educating through networking and online courses.
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...Obaid Ali / Roohi B. Obaid
This presentation discusses the cultural relationship between drug quality and prevailing regulatory environments. It notes that drug quality has evolved from a moral obligation to real challenges, and asks whether the quality of drugs consumed by Pakistani citizens meets minimum global standards. The presentation expresses sincere concern over the quality of drugs used by citizens and asks why quality drugs are not available for Pakistanis. It questions how and who made the Drug Regulatory Authority of Pakistan incompetent, and suggests that if DRAP became competent, drug quality would improve. The presentation concludes by emphasizing the need to make decisions to protect one's loved ones and not allow lives to be put at risk by drugs that do not meet minimum quality standards.CCK Dashboard 2019: Microbiology; A Critical Area
Sterile & Non-sterile products need control of micro-organisms throughout the manufacturing process & facility
Accelerating Generic Approvals by Dr Anthony Crasto
Generic drug companies are relying heavily on qualified contract research organizations (CROs) to accelerate their development processes and be first to market after patents expire on branded drugs. CROs provide expertise across development areas like preclinical research, clinical trials management, bioequivalence studies, analytical testing, and ANDA submissions that help generics meet tight deadlines. Successfully demonstrating bioequivalence through bioavailability and dissolution studies is key for regulatory approval and requires CROs with strong laboratory capabilities and experience navigating regulatory requirements.
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
BOC Sciences recently updated its product list of pharmaceutical impurity reference standards to better serve pharmaceutical companies, scientific research units, testing institutions and universities. Visit https://www.bocsci.com/products/impurities-8.html for more information.
Outsourcing BA and BE to CRO
Basic knowledge of the outsourcing, why, how, and when outsourcing. Some advantages, problems, and steps for secure outsourcing.
Quality and Regulatory Affairs
The document discusses the regulatory IND (Investigational New Drug) process for bringing a new drug to market in the United States. It outlines the requirements for submitting an IND application to the FDA, including non-clinical data from animal and early human studies demonstrating safety and effectiveness. Key components that must be addressed are chemistry and manufacturing controls, pharmacology and toxicology data, clinical protocols, and plans for interaction and meetings with FDA regulators during the process.
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
The Impression of Quality by configuration protects by demonstrating that quality is simply not a demonstration, yet it is a propensity. As of late Quality by structure (QbD) has increased a lot of consideration among the pharmaceutical business in extremely short course of time . It goes about as a connection between the business and medication administrative specialists for example (FDA), which is predominantly founded on logical, chance based, all encompassing and proactive methodology for advancement of pharmaceutical item. QbD has helped in making the new detailing, and furthermore the structuring of new method of medication conveyance, just as the better approaches for assembling procedure, and attempts to guarantee the predefined quality items . Key attributes of QbD are that it gives an apparatus to centered and effective medication improvement. It is pertinent to diagnostic strategies. Key components of the Quality by configuration are The Quality Target Product Profile (QTPP), Critical Quality Attributes (CAQ), Design space, Control procedure, lifecycle the executives . Use of value by configuration is in different new looks into dependent on HPLC technique, and we give quit estimation of medication conveyance as indicated by the patients BMR , additionally in Quality by Design in Biopharmaceuticals .
Conducting Clinical Trials in Asia: Global Engage.May.2013
Medpace Director of Clinical Operations Mainfong Ang, presented a current view of best practices in Asia at the Global Engage conference, May 2013
Pharmaceutical Industry
The pharmaceutical industry is classified into drug discovery and manufacturing groups. Drug discovery involves the research and development of new drug molecules and takes 3-6 years at a cost of $0.5-1 million. Manufacturing produces active pharmaceutical ingredients, generics, and biologics through production, quality control, and other departments. Leaders in research and development are usually PhDs while manufacturing roles require degrees in fields like chemistry, pharmacy, and biotechnology.
Quality by design
This document discusses Quality by Design (QbD), which is a strategic process for drug development and manufacturing to ensure intended performance in terms of purity and efficacy. QbD has four key components: defining product design goals, discovering the process design, understanding the control space, and targeting the operating space. It is a tool for efficient drug development that relies on building quality in from the beginning. Benefits include eliminating failures, reducing costs, and ensuring consistent quality. Key elements include defining quality targets, identifying attributes, performing risk analysis, determining critical aspects, and establishing a control strategy.
Cr and opportunities by bhumika
This document provides an overview of clinical research and career opportunities in the field. It defines clinical research as organized studies conducted on humans to evaluate the safety and efficacy of drugs, medical devices, and other therapies. Various types of clinical research are described. The document outlines the clinical research process and regulations, and notes the growth of the industry in India. Career opportunities are discussed for various roles in clinical research organizations, pharmaceutical companies, and other settings. Requirements and top cities for clinical research in India are also summarized.
Clinical Research Presentation
Clinical research involves conducting research studies in human volunteers to answer health questions and find new treatments. It typically involves several phases from preclinical testing in animals to clinical trials in human subjects. India is emerging as a global hub for clinical research due to its large patient pools, low costs, and trained professionals. However, there is a large gap between the growing demand for trained clinical research professionals and current supply. Cliniminds aims to address this need by providing a wide range of clinical research training programs and courses.
More Related Content
What's hot
Pharmaceuticals Dashboard 2021
This document announces a professional development session on the pharmaceuticals dashboard for 2021. It will discuss topics like uncertainty in quality, the future of manufacturing and regulations, and competitiveness with trade barriers. The session aims to help professionals mature their skills and align with emerging expectations. It will use tutorials, discussions, examples and case studies. Participant assessment will be confidential. The session facilitators have extensive regulatory experience in Pakistan and international agencies. It will be held on December 19th in Karachi with a small group size.
Process development
The document discusses the process of developing, optimizing, characterizing, and commercializing a pharmaceutical product. It involves designing a manufacturing process to consistently deliver the intended effects of the drug product. Process development includes determining facility, equipment, materials, procedures, and validation. Optimization compares lead compounds to select those with the greatest potential to be safe and effective medicines. Characterization tests understand the physical and chemical properties of materials. Commercialization requires approvals from regulators and establishing manufacturing, distribution, and marketing capabilities to introduce the product into markets. The goal is to produce a drug that is safe, effective, and affordable to improve patient health.
Outsourcing in Clinical Research
Outsourcing is a Cost-effective strategy when used properly and at present is gaining more and more importance. Here's a short presentation about the importance of outsourcing in Clinical research.
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Best Practices - Injectable Packaging Lines
In the past couple of years we have seen many companies recalling sterile products, primarily due to the problems related to particulate matter and/ or sterility assurance. These problems are not only a potential threat to the patient health, but also lead to short supply due to contamination, manufacturing problems, or product discontinuation. Sterile dosage forms are vulnerable to both microbial and particulate contamination, which has been traced to glass and packaging materials, problems such as leaching and sorption and moreover the manufacturing/ operating practices.
Recently, in an industry workshop I had shared my thoughts, views, experiences and study findings on this topic and I am happy to share the same with you. I hope this will be useful…
Drug Regulatory Affairs
Drug Regulatory Affairs refers to all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation.
0rganisation of pharmaceutical industry
This document discusses organizational structures for pharmaceutical quality assurance. It states that the heads of production and quality control must be independent of each other according to EU GMP guidelines. It also lists the typical educational backgrounds needed for various roles in pharmaceutical production, quality assurance/quality control, and management. Finally, it provides a flow chart illustrating the process flow from receiving to shipping in a pharmaceutical manufacturing facility.
Drug Regulatory Affairs
This document provides an overview of regulatory affairs for drugs. It defines key terms like regulatory affairs, dossier, CTD, eCTD, DMF, NDA, ANDA, and INDA. It describes the role of regulatory affairs experts in guiding product development according to regulatory requirements, compiling dossiers for submission, and ensuring post-marketing compliance. The document outlines a 10 step process for regulatory product development and regulatory submission preparation. It also discusses quality management systems for regulatory compliance and the role of regulatory affairs in marketing and advertising compliance.
Role of CRO’s in Medical Innovation and Drug Development
Critical medical conditions such as new threats from chronic diseases and their debilitating conditions require quick responses and consistent attempts on a global level. Therefore, when the medical equipment and pharmaceutical biotechnology companies are in need to introduce efficient and effective drugs faster to the market, that is the time when they also need partners who are able to collaborate and assure them effortless development and service delivery.
Regulatory Affairs as a Career Path
The document provides an overview of regulatory affairs as a career. It discusses why regulatory is an important and impactful field, the types of work involved including advising companies on regulations and preparing submissions. It outlines the growth potential within regulatory affairs and necessary skills such as being analytical and having strong writing abilities. The document also discusses where to learn about regulations from sources like the FDA and how to continue self-educating through networking and online courses.
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...Obaid Ali / Roohi B. Obaid
This presentation discusses the cultural relationship between drug quality and prevailing regulatory environments. It notes that drug quality has evolved from a moral obligation to real challenges, and asks whether the quality of drugs consumed by Pakistani citizens meets minimum global standards. The presentation expresses sincere concern over the quality of drugs used by citizens and asks why quality drugs are not available for Pakistanis. It questions how and who made the Drug Regulatory Authority of Pakistan incompetent, and suggests that if DRAP became competent, drug quality would improve. The presentation concludes by emphasizing the need to make decisions to protect one's loved ones and not allow lives to be put at risk by drugs that do not meet minimum quality standards.CCK Dashboard 2019: Microbiology; A Critical Area
Sterile & Non-sterile products need control of micro-organisms throughout the manufacturing process & facility
Accelerating Generic Approvals by Dr Anthony Crasto
Generic drug companies are relying heavily on qualified contract research organizations (CROs) to accelerate their development processes and be first to market after patents expire on branded drugs. CROs provide expertise across development areas like preclinical research, clinical trials management, bioequivalence studies, analytical testing, and ANDA submissions that help generics meet tight deadlines. Successfully demonstrating bioequivalence through bioavailability and dissolution studies is key for regulatory approval and requires CROs with strong laboratory capabilities and experience navigating regulatory requirements.
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
BOC Sciences recently updated its product list of pharmaceutical impurity reference standards to better serve pharmaceutical companies, scientific research units, testing institutions and universities. Visit https://www.bocsci.com/products/impurities-8.html for more information.
Outsourcing BA and BE to CRO
Basic knowledge of the outsourcing, why, how, and when outsourcing. Some advantages, problems, and steps for secure outsourcing.
Quality and Regulatory Affairs
The document discusses the regulatory IND (Investigational New Drug) process for bringing a new drug to market in the United States. It outlines the requirements for submitting an IND application to the FDA, including non-clinical data from animal and early human studies demonstrating safety and effectiveness. Key components that must be addressed are chemistry and manufacturing controls, pharmacology and toxicology data, clinical protocols, and plans for interaction and meetings with FDA regulators during the process.
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
The Impression of Quality by configuration protects by demonstrating that quality is simply not a demonstration, yet it is a propensity. As of late Quality by structure (QbD) has increased a lot of consideration among the pharmaceutical business in extremely short course of time . It goes about as a connection between the business and medication administrative specialists for example (FDA), which is predominantly founded on logical, chance based, all encompassing and proactive methodology for advancement of pharmaceutical item. QbD has helped in making the new detailing, and furthermore the structuring of new method of medication conveyance, just as the better approaches for assembling procedure, and attempts to guarantee the predefined quality items . Key attributes of QbD are that it gives an apparatus to centered and effective medication improvement. It is pertinent to diagnostic strategies. Key components of the Quality by configuration are The Quality Target Product Profile (QTPP), Critical Quality Attributes (CAQ), Design space, Control procedure, lifecycle the executives . Use of value by configuration is in different new looks into dependent on HPLC technique, and we give quit estimation of medication conveyance as indicated by the patients BMR , additionally in Quality by Design in Biopharmaceuticals .
Conducting Clinical Trials in Asia: Global Engage.May.2013
Medpace Director of Clinical Operations Mainfong Ang, presented a current view of best practices in Asia at the Global Engage conference, May 2013
Pharmaceutical Industry
The pharmaceutical industry is classified into drug discovery and manufacturing groups. Drug discovery involves the research and development of new drug molecules and takes 3-6 years at a cost of $0.5-1 million. Manufacturing produces active pharmaceutical ingredients, generics, and biologics through production, quality control, and other departments. Leaders in research and development are usually PhDs while manufacturing roles require degrees in fields like chemistry, pharmacy, and biotechnology.
Quality by design
This document discusses Quality by Design (QbD), which is a strategic process for drug development and manufacturing to ensure intended performance in terms of purity and efficacy. QbD has four key components: defining product design goals, discovering the process design, understanding the control space, and targeting the operating space. It is a tool for efficient drug development that relies on building quality in from the beginning. Benefits include eliminating failures, reducing costs, and ensuring consistent quality. Key elements include defining quality targets, identifying attributes, performing risk analysis, determining critical aspects, and establishing a control strategy.
What's hot (20)
Role of CRO’s in Medical Innovation and Drug Development
Role of CRO’s in Medical Innovation and Drug Development
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Accelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony Crasto
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
Conducting Clinical Trials in Asia: Global Engage.May.2013
Conducting Clinical Trials in Asia: Global Engage.May.2013
Similar to Pharmaceutical Sciences
Cr and opportunities by bhumika
This document provides an overview of clinical research and career opportunities in the field. It defines clinical research as organized studies conducted on humans to evaluate the safety and efficacy of drugs, medical devices, and other therapies. Various types of clinical research are described. The document outlines the clinical research process and regulations, and notes the growth of the industry in India. Career opportunities are discussed for various roles in clinical research organizations, pharmaceutical companies, and other settings. Requirements and top cities for clinical research in India are also summarized.
Clinical Research Presentation
Clinical research involves conducting research studies in human volunteers to answer health questions and find new treatments. It typically involves several phases from preclinical testing in animals to clinical trials in human subjects. India is emerging as a global hub for clinical research due to its large patient pools, low costs, and trained professionals. However, there is a large gap between the growing demand for trained clinical research professionals and current supply. Cliniminds aims to address this need by providing a wide range of clinical research training programs and courses.
Pharmaceutical Quality - The Office of
The keynote address at the Fall meeting of the CPPR Industrial Advisory Board and the Site Directors held yesterday (27 October 2014) at Purdue University. The talk provides a perspective on the recent organizational changes announced by FDA CDER - the Office of Pharmaceutical Quality.
Largest laboratory conference in the Middle East
The MEDLAB Congress will host 6 multi-disciplinary conference tracks that will provide CME Credits, unparalleled education and management solutions to help labs excel in today's competitive market.
5,000 delegates will gather to find out about the latest diagnostics developments at the six conference tracks: laboratory management, microbiology, immunology, haematology, clinical chemistry and molecular diagnosis.
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
The Ohio State University's Drug Development Institute (DDI) aims to accelerate innovative cancer research and speed cures to patients. DDI bridges the gap between Ohio State's strengths in early discovery and clinical development. DDI identifies promising molecules and technologies, partners with companies, and manages projects through various stages including target validation, lead identification, lead optimization, pre-clinical candidate development, and phase I clinical trials. DDI's team has experience in molecular biology, medicinal chemistry, clinical pharmacology, and clinical development. The document outlines DDI's services and approach, and advertises a "Drug Development Bootcamp" event focused on practical aspects of positioning research.
CRSIC Seminar Brochure 15 October 2016
National Seminar on " CLINICAL APPROACH FOR DRUG DELIVERY SYSTEMS
ADHERENCE TO REGULATORY REQUIREMENTS", Mumbai
CRSIC Seminar Brochure 15 october 2016, Mumbai
One Day National Seminar On “ Clinical Approach for Drug delivery Systems - Adherence to Regulatory Requirements"
Cancer Genetics Investor Deck
This document provides an overview of Cancer Genetics, Inc. (CGI) and their focus on being an oncology diagnostics partner from bench to bedside. Some key points:
- CGI utilizes targeted acquisitions and collaborations with research institutions to expand their testing capabilities and global footprint.
- They have a proprietary portfolio of over 20 genomic tests and panels focused on cancers like blood cancers, lymphomas, lung cancer, and solid tumors.
- CGI partners with leading biopharma companies, supporting over 120 clinical trials with testing and services. They have contracts with 8 of the top 10 biopharma companies.
Blueprints to blue sky – analyzing the challenges and solutions for IHC compa...
Manual assessment of biomarker expression is associated with significant inter- and intra reader variability. In some cases there are also limitations when it comes to sensitivity and specificity of manual biomarker assessment.
In one example to the left, the “pure” contribution of inter-reader variability associated with Ki67 assessment was quantified across 20 tumors and 126 participating labs. In that study, it was demonstrated how image analysis can be used to significantly reduce inter-reader variability.
In a another study, the National Danish Validation study of Her2, it was demonstrated how improved sensitivity/specificity of quantitative HER2 protein expression wrt gene amplification lead to significant cost savings in reflex testing.
By automating aspects of stain quality control, it will become scalable to he point where EQA organizations may be able and willing to offer more frequent – perhaps even on-demand – proficiency testing and calibration services.
It is possible that objective and quantitative standards will contribute to improve compliance with protocol recommendations.
In clinical multi-center trials it will be easier to standardize and monitor data from each center.
And it is our hope tha larger diagnostic pathology labs will be able to benefit from such a method by closely monitoring drift in staining quality for biomarkers.
How Pakistan Can Address the Clinical Trial Patient Recruitment Challenge - ...
Ahead of the marcus evans Evolution Summit 2024 and the Evolution Europe Summit 2024, read here an interview with Dr Murtaza Hussain discussing why pharma companies should consider Pakistan for conducting clinical trials.
Anthony Presentation DIA Florida Ctd Nov2007
Creating a business process that is accurate, predictable, and capable of
meeting the changing needs for disclosing information about clinical trials
in multiple study registries and results databases is difficult. Companies
need to leverage their current clinical trial process, determine if the disclosure
steps will be centralized or decentralized, determine how much to
leverage technology, and decide whether, and how, to use outside
resources. During this session, we will hear how a large pharma, a small
biopharmaceutical company, and a device company developed their clinical
trial disclosure business process.
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Join Dr. Danyi Wen as she describes a novel drug efficacy test using Patient Derived Xenograft (PDX) samples to measure drug efficacy and identify therapeutic candidates in personalized oncology treatments.
LIDE’s novel MiniPDX is a 7-day, in vivo drug efficacy test for oncology therapeutics. It is the in vivo version of a 3D organoid assay and correlates with traditional PDX by 92%, and with clinical end point at 82%. These high correlations make MiniPDX an effective option to test targeted drugs, chemotherapies, angiogenesis drugs, and more, while demonstrating superior testing times and cost-effectiveness versus traditional PDX. In a clinical setting, MiniPDX, together with next-generation sequencing (NGS), is playing an emerging role in personalized oncology.
The process starts with a freshly prepared cell suspension from either a clinical sample or PDX (Patient Derived Xenograft) model. This sample is sealed into a mini capsule with 500 KD cut-off pores. Capsules are implanted into SCID mice subcutaneously, and a test compound is given systemically for 7 days. The efficacy of the test compound is then evaluated by measuring ATP of the cancer cells in the capsule.
The MiniPDX mouse trial can also be coupled with “K-Cell Omic” analysis (DNA, RNA, and Protein), presenting a powerful tool for the identification of drug candidates and the discovery of companion diagnostic markers.
Key Topics Include:
Understand how MiniPDX + Omics analysis empowers precision medicine
Pros and cons of functional diagnosis assays (CR, Organoid, MiniPDX, PDX)
How to leverage MiniPDX + Omics for the identification of drug candidates
Role of K Cell RNAseq + FGI (Functional Genomic Imaging)
LIDE’s PMed Trial database for AI aided drug discovery
Best babe cro in india
Veeda CR offers to conduct, manage and monitor Clinical Trials in a wide range of therapeutic areas and monitor BABE studies in India.
CAREER OPPORTUNITIES OF PHARMACY GRADUATES IN THE PHARMACEUTICAL INDUSTRIES.pdf
Pharmacy is a very important profession, which deals with the manufacturing, handing, proper utilization, dispensing, and administration of life saving drugs.
PEGS China-2016-Brochure
In its third year, “PEGS China: Protein and Antibody Engineering & Development Summit” returns to Shanghai for 3 days of inspiring presentations and case studies featuring the latest trends and future potential of China’s biotech industry.
This year’s event comprises four content-driven conferences with over sixty global speakers, plus a new 1-day seminar on clinical & regulatory strategies for global and domestic IND and BLA filings. In addition, dedicated exhibit hall and poster viewing hours will provide invaluable opportunities for networking, deal-making and ideas exchange.
Clinical Research Cktri Presentation
This document summarizes the CKTRI institute, which provides clinical research and data management training programs. It is a joint venture between international organizations and affiliated with clinical research associations. The institute provides hands-on training through classroom lectures, online sessions, a computer lab, library, and projects. It has experienced faculty and offers programs accredited internationally. Students gain skills in areas like clinical research, data management, pharmacology, and regulation. The institute aims to make students proficient in the global clinical research industry and has placement assistance for leading companies.
Vedic Lifesciences Pvt Ltd
Vedic Lifesciences is a contract research organization founded in 2000 that provides drug development services to pharmaceutical companies. It has managed over 34 clinical trials and 248 preclinical studies across multiple therapeutic areas. Services include regulatory submissions, clinical project management, data management, biostatistics, and medical writing. Vedic has experience in areas such as oncology, diabetes, orthopedics, andrology, and inflammation. It employs a team of experts including clinical researchers, medical writers, and regulatory specialists to support its clients.
Vedic Lifesciences Pvt Ltd.
Vedic Lifesciences is a contract research organization founded in 2000 that provides drug development services to pharmaceutical companies. It has managed over 34 clinical trials and 248 preclinical studies across multiple therapeutic areas. Services include regulatory submissions, clinical project management, data management, biostatistics, and medical writing. Vedic has experience in areas such as oncology, diabetes, orthopedics, andrology, and inflammation. It employs a team of experts including clinical researchers, medical writers, and regulatory specialists to support its clients.
Asia Pacific Drug Formulation & Bioavailability Congress
OMICS International invites all the participants across the globe to attend “Asia Pacific Drug Formulation & Bioavailability Congress” september 05-07,2016 Beijing, China. Drug Formulation 2016 is a remarkable event which brings together a unique and International mix of large and medium Pharmaceutical companies / industries, leading universities and research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.
OMICS International Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members
Prof. Melissa Hanna-Brown
This document outlines a presentation on innovative strategies to accelerate drug development. It discusses Pfizer's locations in the UK and facilities for research, manufacturing, and commercial operations. Predictive science approaches using advanced data and technologies are described to enable accelerated development from molecule to medicine. Continuous manufacturing platforms and modular facilities are presented as ways to improve efficiency.
Similar to Pharmaceutical Sciences (20)
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Blueprints to blue sky – analyzing the challenges and solutions for IHC compa...
Blueprints to blue sky – analyzing the challenges and solutions for IHC compa...
How Pakistan Can Address the Clinical Trial Patient Recruitment Challenge - ...
How Pakistan Can Address the Clinical Trial Patient Recruitment Challenge - ...
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
CAREER OPPORTUNITIES OF PHARMACY GRADUATES IN THE PHARMACEUTICAL INDUSTRIES.pdf
CAREER OPPORTUNITIES OF PHARMACY GRADUATES IN THE PHARMACEUTICAL INDUSTRIES.pdf
Asia Pacific Drug Formulation & Bioavailability Congress
Asia Pacific Drug Formulation & Bioavailability Congress
More from Obaid Ali / Roohi B. Obaid
A Strategic Talk on Biologicals & Biotechnological Products
The document discusses anti-thymocyte globulin (ATG), which is used for acute organ rejection. ATG is produced from rabbits that are inoculated with human T lymphocytes to trigger an antibody response. The antibodies produced in rabbits are then extracted, purified, and administered to patients to kill arrays of lymphocytes. Developing a process to characterize the target globulin and transferring knowledge will help establish protein production. Key challenges include maintaining clean environments and aseptic extraction, purification, and filling processes.
Centre for Quality Sciences-Information File-2024.pdf
The document discusses establishing the OR Centre for Quality Sciences to provide consulting services to the pharmaceutical and biologics industries regarding quality, regulatory affairs, innovation, and technology. It aims to engage subject matter experts to support academia, industry, and government. The Centre will focus on shifting from a compliance to a quality culture and aligning with new regulatory expectations in a changing technological landscape with advances in areas like artificial intelligence and data sciences. It will provide training, reviews, audits, and other services to support quality systems, documentation practices, regulatory submissions, clinical trials, and more.
A Tragic Resistance to Learn.pdf
An article on contamination of Diethylene Glycol in Pharmaceuticals. Thanks to Dr. Ajaz S. Hussain for all teaching, sharing knowledge and supporting in professional development.
230930.pdf
The document announces a training on demonstrating a quality management system during inspections to be held on September 30, 2023 in Kotri, Sindh. It will provide participants with techniques for showcasing compliance and procedures when regulatory audits occur. A list of attendees is included but not summarized for brevity.
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
The document provides tips for demonstrating a quality management system during an inspection. It advises being simple, clear, truthful, and confident when welcoming inspectors. Assign specific duties to staff and have flexibility. Listen fully to questions before responding, and don't argue - say you will look into issues. Practice mock inspections, recognize potential problems, and maintain your system daily.
Centre for Quality Sciences-2023
The document discusses the services provided by the Centre for Quality Sciences, which include designing new and upgrading existing pharmaceutical manufacturing facilities, conducting GMP audits and training, assisting with regulatory submissions, and providing consulting services regarding quality systems, data integrity, and compliance strategies. The Centre's vision is to shift the industry towards a quality culture through knowledge sharing and facilitating discussions to develop strategic roadmaps. It aims to help companies strengthen quality compliance and sustain their quality management systems in the changing regulatory landscape.
Track, Trace & Understand Science of Life from Real World Evidence.pdf
The document discusses biomarkers, which are measurable indicators of biological states or conditions. It describes biomarkers as tools that can help facilitate medical product development. The document outlines different types, categories, and descriptions of biomarkers. It discusses how biomarkers can be qualified and approved by regulatory agencies like the FDA for specific contexts of use. The document provides examples of biomarkers that have been used for various purposes, such as assessing disease diagnosis, treatment effectiveness, and safety. It also summarizes some biomarkers that have been qualified or considered for qualification by the FDA.
Confidence on Generics.pdf
1) The document discusses the evolution of ensuring drug quality from relying solely on testing to emphasizing proper manufacturing processes and controls.
2) It explains that without understanding the entire manufacturing process, one cannot say a drug is consistent in quality and purity or free of contamination.
3) Current good manufacturing practices (cGMP) help assure drug safety and efficacy by requiring facilities to control manufacturing operations through quality management systems and robust operating procedures.
Neurotoxicity & Neurodegenaration.pdf
The document discusses neurotoxicity and neurodegeneration in drug development. It notes that safety issues, especially related to the cardiovascular system and central nervous system, are among the most common reasons for drug development failure. Biomarkers for early detection of potential neurotoxicity could help improve success rates by facilitating safety screening earlier in the development process. The central nervous system is particularly vulnerable, as neurotoxicity is a frequent cause of failure in both pre-clinical and clinical phases of development.
Application of Data & AI in Pharma 4
Mr. Atiq ur Rahman has over 27 years of experience in pharmaceutical manufacturing and supply chain management. He has expertise in facility design, quality audits, and regulatory compliance. More recently, he has worked on data engineering, data acquisition, and applying data science concepts in pharmaceutical and other process industries. The presentation provides an overview of the industrial revolutions from Industry 1.0 to 5.0 and defines Pharma 4.0 as the convergence of people, systems, and data within a singular network powered by artificial intelligence. It discusses strategies for digital transformation and achieving digital maturity, including evaluating current technology needs and creating a roadmap with goals and timelines.
PICS-ICH
The document discusses the relationship between PIC/S and ICH and their roles in harmonizing GMP standards globally. PIC/S focuses specifically on GMP inspections and developing harmonized GMP standards and training inspectors. ICH focuses more broadly on safety, efficacy, quality and regulatory guidelines. Together they aim to promote reliance between regulatory authorities and open doors of trust through mutual recognition agreements and understanding of inspection systems. The document provides a comprehensive overview of their goals and collaboration to harmonize standards for patients worldwide.
Quality Affairs of Pharmaceuticals
The document discusses a presentation on quality issues observed by the FDA during inspections of pharmaceutical facilities in 2022. It notes the FDA observed deficiencies related to lack of written SOPs, insecure data, failure to investigate out of specification results, cleaning issues, and missing environmental monitoring programs. The document also presents a case study of a facility that had a significant media fill failure in November 2021 but did not initiate a recall until April 2022, exposing patients to risk. It describes poor aseptic techniques observed by FDA investigators during manufacturing operations.
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
The filling machine and HEPA filter located directly above the filling machine in the filling room were significantly discolored with an unknown substance. This indicates potential contamination issues that need to be investigated and addressed. Facilities should ensure machinery and equipment are properly cleaned and maintained to prevent contamination that could compromise product quality.
CQS Session - RO - 16 Oct 2022.pdf
The document discusses the pressure of real-world evidence on pharmaceutical regulatory science. It mentions the author's experience interacting with international regulatory agencies like the FDA, EU, Health Canada, and MHRA. It lists some references on topics like continuous manufacturing and real-time dissolution prediction. The document emphasizes that improving individual parts of a system will not improve the overall system, and that a systems approach to quality is needed.
GMP Session for Professional Development.pdf
This document provides information about an upcoming training session on Good Manufacturing Practices. The session will be held on October 16th in Karachi and will run from 9:00 am to 3:00 pm. It is aimed at pharmaceutical professionals with backgrounds in pharmacy, chemistry, microbiology and related fields. Experts from the US pharmaceutical industry will discuss advancements in manufacturing technology and emerging regulatory changes. The session will include tutorials, discussions, and Q&A to help participants better understand GMP requirements and ensure quality assurance. Participants will pay Rs. 10,000 or Rs. 5,000 depending on whether they are attending as part of their job. More details and contact information are provided.
Q & A - June - Sep 2022.pdf
This document contains questions and answers related to pharmaceutical quality and manufacturing. It discusses topics like clean hold time, dirty hold time, contamination control strategies, particles in injections, the differences between CMC, GMP, and continuous manufacturing. It also addresses questions about PIC/S, such as whether they issue membership, if inspections by one country are accepted by others, and that GMP certificates are issued by individual regulatory authorities rather than PIC/S.
Judging Science & Prior Knowledge Beyond the Line
This document discusses issues that may arise with generic drugs compared to innovator drugs. Bioequivalence studies only show equivalence at a single point in time and do not guarantee equivalence over the lifetime of the drug. Manufacturing the drug involves many variables like people, equipment, materials that could result in potency and dissolution differences compared to the innovator. The document provides data that showed increased hospitalization rates for certain generics compared to the innovator drug. It emphasizes the need for consistent quality manufacturing to ensure patient safety.
Maturing Drug Quality to Deliver Promise
The document discusses several topics related to improving drug quality including:
1) Evidence from clinical trials and real world use is key to determining drug effectiveness but quality can deteriorate after marketing authorization without a strong quality management system.
2) Errors must be eliminated through quality by design in development and operational excellence, and companies must continuously improve rather than just fixing problems.
3) Digital transformation, identifying critical quality attributes, and moving to more flexible and integrated quality systems will help address issues and improve patient outcomes.
PQRS 2022 - Education
This document appears to be a scanned receipt from a restaurant in New York City listing various food and drink items purchased, with a subtotal of $86.62 and total including tax of $97.45. The receipt details a variety of appetizers, entrees, drinks and desserts ordered for multiple guests.
4 - GMP June 2022 - CQS.pdf
This document discusses key elements of good manufacturing practices (GMP) for pharmaceutical manufacturing. It covers topics like building layout, equipment, utilities, documentation, materials, production processes, packaging, quality systems, facilities, laboratories and ensuring the safety, efficacy and quality of pharmaceutical products. The overall message is that GMP provides a foundation and framework to establish process and quality control, validate operations, continuously improve and ultimately ensure that pharmaceutical products meet their intended quality standards.
More from Obaid Ali / Roohi B. Obaid (20)
A Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological Products
Centre for Quality Sciences-Information File-2024.pdf
Centre for Quality Sciences-Information File-2024.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
Recently uploaded
12 steps to transform your organization into the agile org you deserve
During an organizational transformation, the shift is from the previous state to an improved one. In the realm of agility, I emphasize the significance of identifying polarities. This approach helps establish a clear understanding of your objectives. I have outlined 12 incremental actions to delineate your organizational strategy.
Credit-Management seminar for cooperative power point presentation
Credit-Management seminar for cooperative power point presentation
在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样
学校原件一模一样【微信：741003700 】《(Murdoch毕业证书)莫道克大学毕业证电子版成绩单》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Colby Hobson: Residential Construction Leader Building a Solid Reputation Thr...
Colby Hobson stands out as a dynamic leader in the residential construction industry. With a solid reputation built on his exceptional communication and presentation skills, Colby has proven himself to be an excellent team player, fostering a collaborative and efficient work environment.
Strategic Org Design with Org Topologies™
Org Design is a core skill to be mastered by management for any successful org change.
Org Topologies™ in its essence is a two-dimensional space with 16 distinctive boxes - atomic organizational archetypes. That space helps you to plot your current operating model by positioning individuals, departments, and teams on the map. This will give a profound understanding of the performance of your value-creating organizational ecosystem.
在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样
学校原件一模一样【微信：741003700 】《(UVic毕业证书)维多利亚大学毕业证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Public Speaking Tips to Help You Be A Strong Leader.pdf
In the realm of effective leadership, a multitude of skills come into play, but one stands out as both crucial and challenging: public speaking.
Public speaking transcends mere eloquence; it serves as the medium through which leaders articulate their vision, inspire action, and foster engagement. For leaders, refining public speaking skills is essential, elevating their ability to influence, persuade, and lead with resolute conviction. Here are some key tips to consider: https://joellandau.com/the-public-speaking-tips-to-help-you-be-a-stronger-leader/
The Management Guide: From Projects to Portfolio
A presentation on mastering key management concepts across projects, products, programs, and portfolios. Whether you're an aspiring manager or looking to enhance your skills, this session will provide you with the knowledge and tools to succeed in various management roles. Learn about the distinct lifecycles, methodologies, and essential skillsets needed to thrive in today's dynamic business environment.
Integrity in leadership builds trust by ensuring consistency between words an...
Integrity in leadership builds trust by ensuring consistency between words and actions, making leaders reliable and credible. It also ensures ethical decision-making, which fosters a positive organizational culture and promotes long-term success. #RamVChary
Comparing Stability and Sustainability in Agile Systems
Copy of the presentation given at XP2024 based on a research paper.
In this paper we explain wat overwork is and the physical and mental health risks associated with it.
We then explore how overwork relates to system stability and inventory.
Finally there is a call to action for Team Leads / Scrum Masters / Managers to measure and monitor excess work for individual teams.
原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样
学校原件一模一样【微信：741003700 】《(澳洲WSU毕业证书)西悉尼大学毕业证、文凭证书》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Make it or Break it - Insights for achieving Product-market fit .pdf
This presentation was used in talks in various startup and SMB events, focusing on achieving product-market fit by prioritizing customer needs over your solution. It stresses the importance of engaging with your target audience directly. It also provides techniques for interviewing customers, leveraging Jobs To Be Done for insights, and refining product positioning and features to drive customer adoption.
Addiction to Winning Across Diverse Populations.pdf
A anaysis dedicated to identify the addiction on winniing by diverse population
Sethurathnam Ravi: A Legacy in Finance and Leadership
Sethurathnam Ravi, also known as S Ravi, is a distinguished Chartered Accountant and former Chairman of the Bombay Stock Exchange (BSE). As the Founder and Managing Partner of Ravi Rajan & Co. LLP, he has made significant contributions to the fields of finance, banking, and corporate governance. His extensive career includes directorships in over 45 major organizations, including LIC, BHEL, and ONGC. With a passion for financial consulting and social issues, S Ravi continues to influence the industry and inspire future leaders.
原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样
学校原件一模一样【微信：741003700 】《(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
20240608 QFM019 Engineering Leadership Reading List May 2024
Everything I found interesting about Engineering Leadership in May 2024
Ganpati Kumar Choudhary Indian Ethos PPT.pptx
Ganpati Kumar Choudhary Indian Ethos PPT.pptx, The Dilemma of Green Energy Corporation
Green Energy Corporation, a leading renewable energy company, faces a dilemma: balancing profitability and sustainability. Pressure to scale rapidly has led to ethical concerns, as the company's commitment to sustainable practices is tested by the need to satisfy shareholders and maintain a competitive edge.
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...William (Bill) H. Bender, FCSI
Specific ServPoints should be tailored for restaurants in all food service segments. Your ServPoints should be the centerpiece of brand delivery training (guest service) and align with your brand position and marketing initiatives, especially in high-labor-cost conditions.
408-784-7371
Foodservice Consulting + Design
Risk-Management-presentation for cooperatives
Power point presentation for risk management for cooperatives
Resource-mobilization-guide-for-community-based-organizations1.pdf
resource mobilization guidebook for comminute based organizations
Recently uploaded (20)
12 steps to transform your organization into the agile org you deserve
12 steps to transform your organization into the agile org you deserve
Credit-Management seminar for cooperative power point presentation
Credit-Management seminar for cooperative power point presentation
Colby Hobson: Residential Construction Leader Building a Solid Reputation Thr...
Colby Hobson: Residential Construction Leader Building a Solid Reputation Thr...
Public Speaking Tips to Help You Be A Strong Leader.pdf
Public Speaking Tips to Help You Be A Strong Leader.pdf
Integrity in leadership builds trust by ensuring consistency between words an...
Integrity in leadership builds trust by ensuring consistency between words an...
Comparing Stability and Sustainability in Agile Systems
Comparing Stability and Sustainability in Agile Systems
Make it or Break it - Insights for achieving Product-market fit .pdf
Make it or Break it - Insights for achieving Product-market fit .pdf
Addiction to Winning Across Diverse Populations.pdf
Addiction to Winning Across Diverse Populations.pdf
Sethurathnam Ravi: A Legacy in Finance and Leadership
Sethurathnam Ravi: A Legacy in Finance and Leadership
20240608 QFM019 Engineering Leadership Reading List May 2024
20240608 QFM019 Engineering Leadership Reading List May 2024
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
Resource-mobilization-guide-for-community-based-organizations1.pdf
Resource-mobilization-guide-for-community-based-organizations1.pdf
Pharmaceutical Sciences
- 1. Microbiology & Pharmaceutical Transformation DRAP Lead for Scientific Transformation Initiatives Alumni CDER-USFDA, HPFB-Health Canada Honorary Adviser OR - Centre for Quality Science Federal Urdu University of Arts, Science & Technology Karachi the 15 December 2021 Obaid Ali, RPh., PhD.
- 2. Thank you all Dr. Sadia Khalil & colleagues Disclaimer Personal Point of view based on knowledge and experience gained in the last three decades
- 7. Similar CMC Plant Claim
- 10. Microbiology & Pharmaceutical Transformation DRAP Lead for Scientific Transformation Initiatives Alumni CDER-USFDA, HPFB-Health Canada Honorary Adviser OR - Centre for Quality Science Federal Urdu University of Arts, Science & Technology Karachi the 15 December 2021 Obaid Ali, RPh., PhD.